NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

Recent Quotes

View More
Symbol Price Change (%)
AMZN  237.41
-5.55 (-2.28%)
AAPL  270.30
+0.29 (0.11%)
AMD  240.96
-5.31 (-2.16%)
BAC  53.74
-0.29 (-0.54%)
GOOG  341.68
-3.22 (-0.93%)
META  694.46
-11.95 (-1.69%)
MSFT  412.51
-10.86 (-2.57%)
NVDA  179.58
-6.03 (-3.25%)
ORCL  154.00
-6.06 (-3.79%)
TSLA  419.10
-2.71 (-0.64%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.